StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (REGN) stock

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$957.76+5.36 (+0.56%)

Close on Nov 17, 2026Market cap $99.08BP/E 21.2Yield –

Regeneron Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Regeneron Pharmaceuticals's market cap was $102.80B on Nov 11, 2026, against $85.94B a year earlier. Over the last 5 years it ranged from $55.94B to $135.53B, with a median of $83.91B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$102.80B+20.9%
2025Dec 31, 2025$85.02B+3.7%
2024Dec 31, 2024$81.99B-18.0%
2023Dec 29, 2023$99.99B+22.3%
2022Dec 30, 2022$81.76B+15.8%
2021Dec 31, 2021$70.62B+26.8%
2020Dec 31, 2020$55.70B+29.3%
2019Dec 31, 2019$43.10B+0.3%
2018Dec 31, 2018$42.96B-1.4%
2017Dec 29, 2017$43.59B+2.7%
2016Dec 30, 2016$42.44B-32.0%
2015Dec 31, 2015$62.40B+37.9%
2014Dec 31, 2014$45.24B+40.1%
2013Dec 31, 2013$32.29B+100.0%
2012Dec 31, 2012$16.15B+222.2%
2011Dec 30, 2011$5.01B+90.7%
2010Dec 31, 2010$2.63B–

More Regeneron Pharmaceuticals figures

See a number that looks wrong?